Annual ROE
-51.52%
-29.79%-137.09%
December 31, 2023
Summary
- As of February 7, 2025, NVCR annual return on equity is -51.52%, with the most recent change of -29.79% (-137.09%) on December 31, 2023.
- During the last 3 years, NVCR annual ROE has fallen by -57.23% (-1002.28%).
- NVCR annual ROE is now -1002.28% below its all-time high of 5.71%, reached on December 31, 2020.
Performance
NVCR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-40.74%
+3.82%+8.57%
September 30, 2024
Summary
- As of February 7, 2025, NVCR quarterly return on equity is -40.74%, with the most recent change of +3.82% (+8.57%) on September 30, 2024.
- Over the past year, NVCR quarterly ROE has increased by +9.88% (+19.52%).
- NVCR quarterly ROE is now -620.97% below its all-time high of 7.82%, reached on September 30, 2020.
Performance
NVCR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NVCR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -137.1% | +19.5% |
| 3 y3 years | -1002.3% | +19.5% |
| 5 y5 years | +8.5% | +19.5% |
NVCR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -291.5% | at low | -188.9% | +19.5% |
| 5 y | 5-year | -1002.3% | at low | -621.0% | +19.5% |
| alltime | all time | -1002.3% | +23.2% | -621.0% | +51.4% |
NovoCure Limited ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -40.74%(-8.6%) |
| Jun 2024 | - | -44.56%(-9.2%) |
| Mar 2024 | - | -49.08%(-3.0%) |
| Dec 2023 | -51.52%(+137.1%) | -50.62%(+9.2%) |
| Sep 2023 | - | -46.35%(+15.7%) |
| Jun 2023 | - | -40.06%(+24.8%) |
| Mar 2023 | - | -32.09%(+50.8%) |
| Dec 2022 | -21.73%(+65.1%) | -21.28%(+11.8%) |
| Sep 2022 | - | -19.03%(+17.0%) |
| Jun 2022 | - | -16.26%(+12.1%) |
| Mar 2022 | - | -14.51%(+2.9%) |
| Dec 2021 | -13.16%(-330.5%) | -14.10%(+105.5%) |
| Sep 2021 | - | -6.86%(+448.8%) |
| Jun 2021 | - | -1.25%(-135.5%) |
| Mar 2021 | - | 3.52%(-46.3%) |
| Dec 2020 | 5.71%(-230.4%) | 6.55%(-16.2%) |
| Sep 2020 | - | 7.82%(+42.7%) |
| Jun 2020 | - | 5.48%(+15.6%) |
| Mar 2020 | - | 4.74%(-205.6%) |
| Dec 2019 | -4.38% | -4.49%(-76.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -19.29%(-40.9%) |
| Jun 2019 | - | -32.62%(-32.2%) |
| Mar 2019 | - | -48.08%(-15.4%) |
| Dec 2018 | -56.29%(+16.8%) | -56.85%(+8.8%) |
| Sep 2018 | - | -52.25%(+0.8%) |
| Jun 2018 | - | -51.84%(-6.1%) |
| Mar 2018 | - | -55.20%(+10.8%) |
| Dec 2017 | -48.19%(-28.1%) | -49.80%(-9.3%) |
| Sep 2017 | - | -54.91%(-15.2%) |
| Jun 2017 | - | -64.75%(-5.4%) |
| Mar 2017 | - | -68.41%(-0.5%) |
| Dec 2016 | -67.07%(+4.8%) | -68.78%(-9.6%) |
| Sep 2016 | - | -76.07%(+4.1%) |
| Jun 2016 | - | -73.10%(-1.4%) |
| Mar 2016 | - | -74.13%(+2.0%) |
| Dec 2015 | -64.00%(+7.0%) | -72.66%(-13.3%) |
| Sep 2015 | - | -83.85%(+8.2%) |
| Jun 2015 | - | -77.52%(+17.6%) |
| Mar 2015 | - | -65.91%(+56.4%) |
| Dec 2014 | -59.84%(+32.9%) | -42.13% |
| Dec 2013 | -45.04% | - |
FAQ
- What is NovoCure Limited annual return on equity?
- What is the all time high annual ROE for NovoCure Limited?
- What is NovoCure Limited annual ROE year-on-year change?
- What is NovoCure Limited quarterly return on equity?
- What is the all time high quarterly ROE for NovoCure Limited?
- What is NovoCure Limited quarterly ROE year-on-year change?
What is NovoCure Limited annual return on equity?
The current annual ROE of NVCR is -51.52%
What is the all time high annual ROE for NovoCure Limited?
NovoCure Limited all-time high annual return on equity is 5.71%
What is NovoCure Limited annual ROE year-on-year change?
Over the past year, NVCR annual return on equity has changed by -29.79% (-137.09%)
What is NovoCure Limited quarterly return on equity?
The current quarterly ROE of NVCR is -40.74%
What is the all time high quarterly ROE for NovoCure Limited?
NovoCure Limited all-time high quarterly return on equity is 7.82%
What is NovoCure Limited quarterly ROE year-on-year change?
Over the past year, NVCR quarterly return on equity has changed by +9.88% (+19.52%)